ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- University of Minnesota
- Study ID
- NCT05628194
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Observational/Survery — OTHERMSM participants will complete a one-time survey, delivered in an e-format. Survey will be accessible via Meta-based social media platforms (Facebook, Instagram).
Study Details
The purpose of this study is to describe current knowledge and opinions about anal cancer screening among men who have sex with men (MSM), as well as their experience receiving guideline-compliant care aimed at anal cancer risk reduction using a large-scale survey disseminated via social media.
Key Dates
- Start date
- Jun 8, 2023
- Status verified
- Aug 2025
- Primary completion
- Jun 30, 2026
- Completion
- Jun 30, 2026
Study Design
- Enrollment
- 5,000 participants (estimated)
Arms
- Arm: Men who have sex with men (MSM)
Primary Outcome Measure
MSM awareness of anal cancer risk [ Time Frame: 2 months ]
Central Contacts
- Kathryn Vera612-625-5018
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Minnesota | Minneapolis | Minnesota | 55455 |
Find similar trials in Minneapolis, MN
By research site
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Detecting HPV DNA in Anal and Cervical CancersRecruiting · University of Chicago · Chicago, Illinois
- Virtual Reality for GI Cancer Pain to Improve Patient Reported OutcomesRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated CancersPHASE1/PHASE2 · Recruiting · Christian Hinrichs · New Brunswick, New Jersey